FIBROBLASTY KOZhI ZARODYShEY I IKh UChASTIE V REGENERATsII KOZhNYKh RAN I SKELETNYKh MYShTs
- Authors: Sheveleva ON1, Ramazanova SG1, Payushina OV1, Butorina NN1
-
Affiliations:
- Issue: Vol 16, No 4 (2016)
- Pages: 244-245
- Section: Articles
- URL: https://journals.eco-vector.com/MAJ/article/view/9766
- DOI: https://doi.org/10.17816/MAJ164244-245
- ID: 9766
Cite item
Abstract
Full Text
About the authors
O N Sheveleva
Email: on_sheveleva@mail.ru
S G Ramazanova
O V Payushina
N N Butorina
References
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement / Dominici M., Le Blanc K., Mueller.I, Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop Dj., Horwitz E. // Cytotherapy.- 2006.- Vol. 8 (4).- P. 315-317.
- Treatment of inflammatory diseases with mesenchymal stem cells / Newman R. E., Yoo D., LeRoux M. A., Danilkovitch-Miagkova A. // Inflamm Allergy Drug Targets.- 2009.- Vol. 8 (2).- P. 110-123.
- Muscle regeneration by bone marrow-derived myogenic progenitors / Ferrari G., Cusella-De Angelis G., Coletta M., Paolucci E., Stornaiuolo A., Cossu G., Mavilio F. // Science.- 1998.- Vol. 279 (5356) - P. 1528-1530.
- Caplan A. I. Why are MSCs therapeutic? New data: new insight // J. Pathol.- 2009.- Vol. 217 (2).- P. 318-324.